ISRCTN21534255 : Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
- Overall trial status
- Completed
- Recruitment status
- No longer recruiting
Published
Serbia
Nervous System Diseases
Published
Serbia
Nervous System Diseases
Published
Serbia
Nervous System Diseases
Published
Serbia
Nervous System Diseases